<DOC>
	<DOCNO>NCT01481623</DOCNO>
	<brief_summary>Type 1 Diabetes multifactorial disease , strong genetic contribution HLA gene , minor contribution many additional gene . The investigator hypothesis addition multifactorial inheritance , subtypes diabetes cause defect single gene ( monogenic diabetes ) . The aim project identify gene , base detailed clinical characterization patient , describe correspond genetic diabetes entity respect genetic molecular defect , clinical feature biochemistry . Based investigator study design , diabetes entity cause mutation affect two copy correspond gene . In addition , investigator study relatives patient , explore carrier genetic defect ( i.e . one copy gene defective ) may predisposition common form diabetes , mainly type 2 diabetes .</brief_summary>
	<brief_title>Identification Characterization Monogenic Diabetes</brief_title>
	<detailed_description>In first phase study investigator recruit patient family , strong bias `` extreme '' form diabetes ( early onset and/or syndromic diabetes ) familial context suggestive monogenic inheritance ( e.g . consanguinity , multiplicity diabetic sibling ) perform genetic study identify gene . After obtain informed consent , investigator collect clinical information diabetes associate disease feature , family information diabetes , collect blood sample DNA , RNA , serum cell line . The investigator perform genetic study identify gene responsible monogenic form diabetes . After identification gene , second phase study test consequence carrier status identify mutation metabolic trait relate glucose metabolism . For , obtain informed consent , investigator extend recruitment initial family ( gene identification ) recruit relative may carriers mutation . The investigator determine carrier status subject perform detailed clinical description well metabolic study evaluate glucose metabolism . This study lead identification new monogenic diabetes entity , correspond gene , may also result identification new gene predispose common form diabetes . This project implication diagnosis monogenic form diabetes , may result case improve care patient , include prevention treatment .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>First phase : `` extreme '' form diabetes , base clinical , phenotypic familial criterion . Parents sibling proband sample . Second phase : ( gene identification ) : relative proband , potential carrier mutation Non consent participate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>neonatal</keyword>
	<keyword>consanguinity</keyword>
	<keyword>monogenic</keyword>
	<keyword>metabolism</keyword>
</DOC>